Live Quote · NASDAQRAREHealthcare· Biotechnology

Ultragenyx Pharmaceutical Inc.

$16.48▼ 4.30%($-0.74)
MKT CAP $1.68BNEXT EARNINGS Feb 11, 2027
50%
Bullish
TickerSpark Score
65/100
▌ Solid
90
Valuation
60
Profitability
75
Growth
52
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RARE research report →

Analyst Price Target
$25.54+55.0% vs. today

Range $16 – $39

Analyst RatingBuy
21 Buy12 Hold1 Sell

Price Chart

-47.15% · this period
$36.54$24.71$12.88Nov 20May 26Nov 20
52-Week Range14% of range
Low
$12.73
Current
$16.48
High
$39.89